Jon Jones failed an in-competition urine screening just after the UFC 214 weigh-ins on July 28. It is now being reported that Jones passed a USADA-administered blood test shortly after the July 29 event. Ariel Helwani of MMA Fighting was the first to report the news.
Iain Kidd of Bloody Elbow, known for his knowledge in performance-enhancing drugs in combat sports, notes that turinabol — the drug Jones tested positive for on July 28 — is detected in urine tests, not blood tests. That explains how the two examinations differ.
MMA Fighting reports that Jones also passed USADA-administered drug screenings on July 6 (blood) and July 7 (urine).
Jones defeated Daniel Cormier at UFC 214 to regain the UFC light heavyweight championship, a crown Jones is now at risk of being stripped of due to the failed test.
Jones tested positive for turinabol, an anabolic steroid, during the pre-fight screening. He’s been handed a provisional suspension for the test, and could face a suspension of up to four years if found guilty. It is unclear how much of the banned substance was found in Jones’ system, or how long it would have taken for that amount to have exited his body entirely, making future urine tests key developments once revealed.
Now allegedly a multiple-time offender, Jones first tested positive in a drug screening in July of last year, flagged for clomiphene. The light heavyweight champion successfully argued that the substance was in his system as a result of a tainted male-enhancement supplement but still received a yearlong ban for negligence.
The 30-year-old fighter’s camp has once again cried foul. Jones’ manager, Malki Kawa, has argued that this is likely a result of another tainted supplement, while one of the coaches at Jackson-Wink MMA has called the situation a “setup.”
Jones is widely regarded as the greatest mixed martial artist of all time, a moniker that may no longer be bestowed on him if found guilty.